The amendment is credit-positive for Balchem's liquidity and cost of debt, but is a routine refinancing with no earnings or operational catalyst. Monitor the next 10-Q for any change in leverage or use of the expanded facility.
Price Chart
Executive Summary
Balchem amended its existing credit agreement, increasing the revolving commitment from $550M to $650M, extending the maturity from July 2027 to July 2031, adding a Dutch subsidiary (Balchem B.V.) as a foreign borrower, and reducing the applicable margin on Tier 3 and 4 loans by 12.5 bps. KeyBank was repaid and exited the facility. This is a routine refinancing that improves liquidity and lowers borrowing costs, but does not reflect any change in underlying business fundamentals or earnings.
Key Financial Metrics
Key Facts
- Aggregate revolving commitments increased from $550M to $650M.
- Maturity date extended from July 27, 2027 to July 24, 2031.
- Balchem B.V. (Netherlands) added as a foreign borrower.
- Applicable margin reduced by 12.5 bps at Tier 3 and Tier 4 leverage levels.
- KeyBank National Association repaid in full and exited as a lender.
- 10 bps SOFR adjustment eliminated.
- No financial data (revenue, EPS, EBITDA) reported in this filing.
Financial Impact
Increased revolving credit capacity by $100M to $650M, extended maturity by 4 years, and reduced borrowing costs by 12.5 bps on certain tiers.
Risk Factors
- Increased debt capacity could lead to higher leverage if fully drawn.
- No financial data provided; the filing does not disclose current leverage or cash position.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-029658 |
| Document: ef20078813_8k.htm | 0001140361-26-029658 |
| Document: ef20078813_ex10-2.htm | 0001140361-26-029658 |
| Document: 0001140361-26-029658-index-headers.html | 0001140361-26-029658 |
| Document: 0001140361-26-029658-index.html | 0001140361-26-029658 |
| Document: 0001140361-26-029658.txt | 0001140361-26-029658 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $175.49 | awaiting T+20 | — | $177.00 (+0.86%) |
Oct 23, 2026 3d ago | Press Release | $175.49 | awaiting T+20 | — | $177.00 (+0.86%) |
Jul 31, 2026 12w ago | 8-K | $167.56 $178.44 | ▲ +6.50% | ▲ +3.51% | $177.00 (+5.64%) |
Jul 31, 2026 12w ago | Press Release | $167.56 $178.44 | ▲ +6.50% | ▲ +3.51% | $177.00 (+5.64%) |
Jul 24, 2026 13w ago | 8-K | $164.79 $177.50 | ▲ +7.71% | ▲ +4.41% | $177.00 (+7.41%) |
Jul 17, 2026 14w ago | Press Release | $163.35 $178.51 | ▲ +9.28% | ▲ +4.83% | $177.00 (+8.36%) |
May 20, 2026 22w ago | Court Ruling | $161.75 $165.57 | ▲ +2.36% | ▲ +2.14% | $177.00 (+9.43%) |
Apr 16, 2026 27w ago | Press Release | $174.45 | awaiting T+20 | — | $177.00 (+1.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers